Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization

被引:45
作者
Hu, QX
Trent, JO
Tomaras, GD
Wang, ZX
Murray, JL
Conolly, SM
Navenot, JM
Barry, AP
Greenberg, ML
Peiper, SC [1 ]
机构
[1] Univ Louisville, James Graham Brown Canc Ctr, Henry Vogt Canc Res Inst, Louisville, KY 40202 USA
[2] Duke Univ, Med Ctr, Dept Surg, Ctr AIDS Res, Durham, NC 27710 USA
关键词
HIV-1; tropism; virus coreceptor; envelope structure;
D O I
10.1006/jmbi.2000.4076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The V3 loop of the ENV glycoprotein exerts a dominant influence on the interaction of gp120 with coreceptors. Primary env genes cloned from sequential isolates from two seroconverters revealed Pro --> Ala conversion in the conserved GPG motif of the V3 crown in seven of 17 R5 ENV. ENV containing the GPG motif in the V3 crown had fusogenic activity with chimeric receptors containing either the N terminus or loops of CCR5, whereas those with the GAG variant utilized only the former. Site-directed mutagenesis of multiple primary and prototypic R5 env genes demonstrated that the GPG motif was necessary for dual utilization of the N terminus and body of CCR5 in both gain and loss-of-function experiments. All ENV containing the GPG V3 crown showed CCR5 binding in the presence of soluble CD4, whereas it was not detected with the GAG variants. Molecular dynamic simulations of a V3 peptide predicts that the Pro --> Ala substitution results in a conformational change with loss of the crown structure. These studies demonstrate that sequences in the third hypervariable region determine the specificity of coreceptor utilization for fusion, and that a conserved motif in the crown directly influences the molecular anatomy of the interaction between gp120 and CCR5. (C) 2000 Academic Press.
引用
收藏
页码:359 / 375
页数:17
相关论文
共 73 条
[21]   Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events [J].
Doranz, BJ ;
Baik, SSW ;
Doms, RW .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10346-10358
[22]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[23]   Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry [J].
Dragic, T ;
Trkola, A ;
Lin, SW ;
Nagashima, KA ;
Kajumo, F ;
Zhao, L ;
Olson, WC ;
Wu, LJ ;
Mackay, CR ;
Allaway, GP ;
Sakmar, TP ;
Moore, JP ;
Maddon, PJ .
JOURNAL OF VIROLOGY, 1998, 72 (01) :279-285
[24]   Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry [J].
Farzan, M ;
Mirzabekov, T ;
Kolchinsky, P ;
Wyatt, R ;
Cayabyab, M ;
Gerard, NP ;
Gerard, C ;
Sodroski, J ;
Choe, H .
CELL, 1999, 96 (05) :667-676
[25]   A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 [J].
Farzan, M ;
Choe, H ;
Vaca, L ;
Martin, K ;
Sun, Y ;
Desjardins, E ;
Ruffing, N ;
Wu, LJ ;
Wyatt, R ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1160-1164
[26]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[27]   Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site [J].
Ghiara, JB ;
Ferguson, DC ;
Satterthwait, AC ;
Dyson, HJ ;
Wilson, IA .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 266 (01) :31-39
[28]   CRYSTAL-STRUCTURE OF THE PRINCIPAL NEUTRALIZATION SITE OF HIV-1 [J].
GHIARA, JB ;
STURA, EA ;
STANFIELD, RL ;
PROFY, AT ;
WILSON, IA .
SCIENCE, 1994, 264 (5155) :82-85
[29]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES [J].
GOUDSMIT, J ;
DEBOUCK, C ;
MELOEN, RH ;
SMIT, L ;
BAKKER, M ;
ASHER, DM ;
WOLFF, AV ;
GIBBS, CJ ;
GAJDUSEK, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4478-4482
[30]   MUTATIONS IN THE PRINCIPAL NEUTRALIZATION DETERMINANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AFFECT SYNCYTIUM FORMATION, VIRUS INFECTIVITY, GROWTH-KINETICS, AND NEUTRALIZATION [J].
GRIMAILA, RJ ;
FULLER, BA ;
RENNERT, PD ;
NELSON, MB ;
HAMMARSKJOLD, ML ;
POTTS, B ;
MURRAY, M ;
PUTNEY, SD ;
GRAY, G .
JOURNAL OF VIROLOGY, 1992, 66 (04) :1875-1883